Neurocrine Biosciences
NBIX
#1280
Rank
NZ$24.89 B
Marketcap
$245.93
Share price
1.00%
Change (1 day)
16.68%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company